We also aimed to investigate the effects of HBOT on the plasma levels of HDL-C,fasting insulin (FI), fasting plasma glucose (FPG), and triglyceride, the abnormal levels of which are risk factors for MetS and DM. Here, INS is linked to metabolic syndrome.